Exagen Inc. XGN Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsNet.
The official record: Exagen Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s deferred tax assets, net of valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s deferred tax assets, net of valuation allowance?
- Exagen Inc. (XGN) reported deferred tax assets, net of valuation allowance of $1.18M in Q4 2025.
- How has Exagen Inc.'s deferred tax assets, net of valuation allowance changed year-over-year?
- Exagen Inc.'s deferred tax assets, net of valuation allowance increased by 66.7% year-over-year, from $708K to $1.18M.
- What is the long-term trend for Exagen Inc.'s deferred tax assets, net of valuation allowance?
- Over 5 years (2020 to 2025), Exagen Inc.'s deferred tax assets, net of valuation allowance has grown at a 13.1% compound annual growth rate (CAGR), from $637K to $1.18M.